×
Hero Background

Anti Nuclear Antibody Testing Companies

ID: MRFR/LS/2319-HCR
72 Pages
Kinjoll Dey
October 2025

Anti-nuclear antibody (ANA) testing is a laboratory test used to detect the presence of antibodies that target the cell nucleus. Elevated levels of ANAs are associated with autoimmune disorders such as systemic lupus erythematosus (SLE) and rheumatoid arthritis. Several companies are involved in providing ANA testing products and services.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Anti-nuclear Antibody (ANA) Testing Market - Forecast To 2035 Infographic
Summary Table of Contents Segmentation Download PDF

Top Industry Leaders in the Anti Nuclear Antibody Testing Market

Anti-nuclear Antibody (ANA) Testing Market

 


Latest Antinuclear Antibody (ANA) Testing Companies Updates:


Quest Diagnostics Acquired certain laboratory testing assets of LabCorp in the US, strengthening its position in the autoimmune testing market.


Eurofins Scientific Acquired ChemWerth, a US-based Contract Research Organization (CRO) specializing in toxicology and drug development, gaining a foothold in the North American market.


Roche Diagnostics Launched the Cobas® Infinity U 11, a high-throughput instrument for automated urine drug screening, offering faster and more efficient testing.


Becton, Dickinson and Company (BD) Received FDA approval for its BD Veritor™ Plus rapid test for fentanyl in saliva, addressing the growing opioid crisis


List of Antinuclear Antibody (ANA) Testing Key companies in the market:



  • Abcam plc. (US)

  • Alere (US)

  • Antibodies Inc.(US)

  • Bio-Rad Laboratories, Inc. (US)

  • Erba Diagnostics (US)

  • Indur Services, Inc. (US)

  • MBL INTERNATIONAL (US)

  • Merck KGaA (Germany)

  • Trinity Biotech (Republic of Ireland)